Atlas Trials

A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Spain, as Part of Local Clinical Practice

Clinical trial NCT05443334 · COMPLETED

Trial details

NCT number
NCT05443334
Sponsor
Novo Nordisk A/S
Status
COMPLETED
Study type
OBSERVATIONAL
Diabetes Mellitus, Type 2
Start date
2022-07-28
Primary completion
2024-07-04
Enrollment
465

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.